Takumi Sato
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Analysis of Molecular Dynamics Simulation Data via Statistical Distances between Covariance Matrices.
Journal: The journal of physical chemistry. B
Published: July 13, 2026
Neurotoxicity of Immunotherapy: Immune Checkpoint Inhibitor-Related Encephalitis vs. Immune Effector Cell-Associated Neurotoxicity Syndrome.
Journal: World journal of oncology
Published: August 25, 2025
Perioperative chemoimmunotherapy for patients with gastric or gastroesophageal junction cancer: a systematic review and meta-analysis.
Journal: JNCI cancer spectrum
Published: July 18, 2025
ASO Author Reflections: Is Mesothelin a Promising Option for Molecular Targeted Therapies in Triple Negative Breast Cancer?
Journal: Annals of surgical oncology
Published: March 21, 2025
Reader Comment Regarding Correlates of improved outcomes in patients with COVID-19 treated in US emergency department.
Journal: The American journal of emergency medicine
Published: February 12, 2025
Encouraging co-targeting of immunoregulatory molecules in cancer treatment.
Journal: Immunotherapy
Published: February 06, 2025
Mesothelin (MSLN) is Highly Expressed in Triple Negative Breast Cancer and is Associated with Enhanced Cell Proliferation and Proinflammatory Tumor Microenvironment.
Journal: Annals of surgical oncology
Published: November 04, 2024
Potential prognostic factors of early-onset colorectal cancer in patients with obesity.
Journal: Surgery
Published: September 14, 2024
RNA-Seq analysis of the fruiting bodies and mycelia of angel-wing mushroom Pleurocybella porrigens that cause acute encephalopathy.
Journal: BMC research notes
Published: May 04, 2024
CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer.
Journal: Research square
Published: April 08, 2024
CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer.
Journal: Breast cancer research and treatment
Published: March 22, 2024
Last Updated: 09/26/2026